Trial Profile
Effects of teneligliptin on glycemic control and bone metabolic markers in diabetic patients undergoing hemodialysis
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 19 Nov 2014
Price :
$35
*
At a glance
- Drugs Teneligliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 18 Nov 2014 Status changed from recruiting to completed according to University Hospital Medical Information Network-Japan record.
- 27 May 2013 New trial record